BIOGAS — Biokraft International AB Cashflow Statement
0.000.00%
- SEK871.58m
- SEK1.64bn
- SEK445.83m
Annual cashflow statement for Biokraft International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.94 | -6.04 | 4.99 | -65.2 | -73.1 |
| Depreciation | |||||
| Non-Cash Items | -16.4 | 18.4 | 7.01 | 0.2 | 21.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -70.2 | -8.71 | -40.5 | -11.6 | -21.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.016 | 89.4 | 55.8 | 7.37 | 22.7 |
| Capital Expenditures | -47.1 | -58.7 | -157 | -279 | -554 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -4.49 | 1.17 | 99.6 | 86 | 126 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.6 | -57.6 | -57.1 | -193 | -428 |
| Financing Cash Flow Items | 11.7 | -15.7 | 7.25 | -2.46 | 18 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 92.6 | 213 | 73.3 | 291 | 143 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 41.6 | 242 | 72.1 | 109 | -265 |